Nuclear Magnetic Resonance Spectroscopy (NMR). 1 H NMR spectra were recorded on a Bruker (400MHz) spectrometer with CDCl3, DMSO and D2O as the solvents and TMS as an internal standard.
by stirring in acetic acid, followed by washing with acetone three times. N3-PEG2K-OH was synthesized according to a literature procedure. [1] Nanosight. To track the movement of the particles, a Nanosight LM10HS instrument (Malvern Instruments) equipped with an Electron Multiplication Charge Coupled Device (EMCCD) camera was used. The camera was mounted on an optical microscope in order to track the light scattered by the injected particles that are present in the focus of an 80 μm beam generated by a single mode laser diode with a 60 mW blue laser (405 nm). The concentration of the particles was between 10 7 and 10 9 particles mL -1 . Samples were injected into the nanosight chamber which has a 0.5 mL volume. The mean square displacement (MSD) of the particles was extracted from NTA 2.2 software. Ultraviolet-visible Spectroscopy (UV/Vis). The UV absorbance spectra were recorded on a Jasco V-650 UV/Vis spectrometer at 293 K.
Asymmetric Flow Field-Flow

Synthesis
Synthesis of mPEG45-b-PS210 and N3-PEG45-b-PS215
The reaction scheme to PEG-b-PS was as follows (Supplementary Scheme 1):
Scheme S1. Synthetic route of mPEG45-b-PS210 and N3-PEG45-b-PS215.
ATRP macro-initiator mPEG45-Br and N3-PEG45-Br were prepared according to literature. [2] mPEG45-b-PS and N3-PEG45-b-PS were synthesized by atom transfer radical polymerization (ATRP). Briefly, mPEG45-Br or N3-PEG45-Br (100 mg, 0.05 mmol), styrene( 2.6 g, 25 mmol) and CuBr (7 mg, 0.05 mmol) were added into a 5 mL round bottom flask, followed by degassing with nitrogen for 30 min. Subsequently, PMDETA (10 μL, 0.05 mmol) dissolved in 0.5 mL toluene was added to the flask, after which the mixture was purged with nitrogen for another 30 min.
Then the flask was placed into a 90 °C oil bath. After the desired monomer conversion was reached, the solution was immersed in a liquid nitrogen bath in order to stop the radical polymerization. Then the solution was diluted in 50 mL of THF and passed through a neutral alumina column twice to remove the copper catalyst. Then the filtrate was concentrated and precipitated into 50 mL methanol twice. The white precipitate was collected and dried in a vacuum oven at room temperature for 24 h. With 1 H NMR ( Figure S1 ), the PS polymerization degrees (DPs) of mPEG45-b-PS and N3-PEG45-b-PS were determined, which are 210 and 215, respectively. The molecular weight and molecular weight distribution were determined by GPC using THF as the eluent ( Figure S2 ). 
Synthesis of DBCO-poly-L-lysine (DBCO-PLL)
The reaction scheme to DBCO-PLL was as follows (Supplementary Scheme 2):
Scheme S2. Synthetic route toward DBCO-PLL.
Synthesis of DBCO-poly(N ε -carbobenzyloxy-L-lysine) (DBCO-PLZ)
The synthesis was modified from previous literature reports. [3] LysZ NCA (3 g, 10 mmol) and
DBCO-NH2 (13.8 mg, 0.05 mmol) were dissolved in 20 mL anhydrous N,N-dimethylformamide (DMF). Then the mixture was allowed to react at room temperature for 48 h under nitrogen. 1 Figure S3a ).
After most of the solvent was removed by evaporation, the mixture was precipitated in excess cold diethyl ether. The precipitates were purified by repeated filtration and then dried in a vacuum oven at room temperature for 24 h.
Synthesis of DBCO-poly(L-lysine) (DBCO-PLL)
DBCO-PLZ200 (600 mg, 0.01 mmol) dissolved in 10 mL DMF with 10% trifluoroacetic acid was 
Stomatocyte assembly
Preparation of stomatocytes with encapsulated HRP mPEG45-b-PS210 (9 mg) and N3-PEG45-b-PS215(1 mg) were dissolved in a 1 mL mixture of THF/dioxane (80:20 v/v), followed by addition of 0.6 mL Milli-Q water via a syringe pump at a rate of 1 mL h −1 . Then 0.4 mL Milli-Q water containing 1 mg HRP was added at the same rate.
Next, the resulting cloudy polymersome/HRP mixture was transferred into a dialysis bag(molecular weight cutoff: 12,000-14,000 Da, flat width 25 mm) and dialyzed against 50 mM sodium chloride with the dialysis solution changed after one hour to generate almost "closed" stomatocytes. After 24 h, the stomatocyte and enzyme mixture was centrifuged for 5 min at 5000 rpm via spin filtration over 0.22 µm membranes. The filtrate was withdrawn and fresh medium was added. This centrifugation process was repeated until no obvious absorption at 403 nm (HRP's characteristic Soret band) was observed from the filtrate, which indicates that free enzymes were completely removed from the stomatocyte solution.
Preparation of PtNPs loaded stomatocytes
mPEG45-b-PS210 (9 mg) and N3-PEG45-b-PS215 (1 mg) were dissolved in a 1 mL mixture of THF/dioxane (80:20 v/v), followed by addition of 1 mL Milli-Q water via a syringe pump at a rate of 1 mL h −1 . Then the resulting cloudy polymersome solution was transferred into a dialysis bag (molecular weight cutoff: 12,000-14,000 Da, flat width 25 mm) and dialyzed against 50 mM sodium chloride with the dialysis solution changed after one hour to generate almost "closed" stomatocytes. After 24 h, the stomatocyte solution was concentrated to 1 mL with a final polymer concentration of 10 mg mL -1 . Then PtNPs were in situ formed inside the stomatocytes. More specifically, 8.8 mg ascorbic acid was completely dissolved in 0.5 mL Milli-Q water, after which 0.5 mL of a 20 mM aqueous solution of K2PtCl4 and 5 mg PVP was added. Then, 0.5 mL of the above mentioned stomatocyte solution was added. The mixture was allowed to stir for 30 min, followed by sonication at room temperature for one hour. Free PtNPs were removed via spin filtration over 0.22 µm membranes. The PtNPs loading efficiency is around 35 % (35% of the cavities contain nanoparticles) according to TEM images of 100 stomatocytes.
Preparation of PLL-modified HRP or PtNPs loaded stomatocytes
To decorate the surface of the stomatocytes with PLL, 1.5 mg DBCO-PLL100 or 3 mg DBCO-PLL200 was added to the above prepared HRP or PtNP loaded stomatocytes. Then the mixture was stirred for 24h at room temperature. Subsequently, free polymers were removed via spin filtration over 0.22 µm membranes (Supplementary Scheme 3 and Scheme 4). The purified stomatocyte solution was lyophilized, and the weight change of the sample was utilized to calculate the coupling efficiency, which is around 94 %.
Scheme S3. Formation of PLL-modified stomatocyte nanoreactors.
Scheme S4. Formation of PLL-modified stomatocyte nanomotors.
Morphology characterization of the stomatocytes
The morphology of the prepared stomatocytes was investigated by TEM and Cryo-TEM. The introduction of PLL on the surface of the stomatocytes did not have any influence on the final structure of the stomatocytes ( Figure S4 and S5). 
Size distributions of the nanoparticles
The sizes and size distributions of stomatocytes, PLL-stomatocytes, HRP-loaded PLLstomatocytes, and Pt-loaded PLL-stomatocytes were measured with a Malvern DLS-Zetasizer (Table S1 ). The attachment of PLL on the surface of the stomatocytes did not induce a size change of the particles as only 10% of the block copolymers was modified by PLL. The encapsulation of PtNPs gave rise to an approximate 20 nm size increase compared with empty stomatocytes and HRP loaded stomatocytes, which might be caused by the entrapment of PtNPs. 
Zeta potential of the nanoparticles
The surface charge changes of the stomatocytes, N3-stomatocytes, and PLL-stomatocytes were measured by a Malvern DLS-Zetasizer. The ATP effects on the zeta potential of the nanoparticles were performed as follows: ATP in different concentrations was added to the PLLstomatocyte solution, and the zeta potential of the mixtures was measured after 60 s. To show that only PLL could interact with ATP to form complexes, the zeta potential changes of the stomatocytes and N3-stomatocytes without PLL after addition of ATP were studied ( Figure S6 ).
Also, the AMP effect on the surface charge change of the nanoparticles compared with ATP was investigated. To study the dynamic zeta potential change of the nanoparticles induced by apyrase, the PLL-stomatocytes were first complexed with ATP (the charge ratio r=1), after which apyrase was applied at different concentrations. The zeta potential changes were recorded every two minutes. Experimental conditions: 0.5 mg mL -1 nanoparticles in MES buffer (5 mM, pH 6.5) and 62.5 μM ATP or 125 μM AMP.
Enzyme encapsulation efficiency
The complete removal of HRP was confirmed by size exclusion chromatography (SEC) ( Figure   S8 ). Encapsulated HRP was released from the stomatocytes by reshaping the bowl-shaped structures back into polymersomes by addition of 200 μL of THF/dioxane (4:1, v/v) directly to the nanoreactors ( Figure S9 ). The released enzymes were collected for analysis of the incorporation efficiency, which was calculated as 9.5% by bicinchoninic acid (BCA) assay. A BCA Protein Assay Kit was purchased from ThermoFisher. The enzyme concentration was determined using a standard BCA protein assay protocol. Briefly, a standard curve of the enzyme was first established using the native enzyme with a series of enzyme concentrations (10 mg mL -1 , 8 mg mL -1 , 6 mg mL -1 , 4 mg mL -1 , 2 mg mL -1 and 1 mg mL -1 ). 25 μL of each standard or unknown sample was pipetted into a microplate well, then 200 μL of the BCA working reagent (50:1, Reagent A:B) was added to each well and the solution was mixed thoroughly on a plate shaker for 30 seconds. After incubation at 37°C for 30 min, the absorbance at 562 nm was recorded in the plate reader. The enzyme concentration was calculated referring to the standard curve.
Confirmation of successful encapsulation of enzymes and PtNPs inside the stomatocytes
To confirm that the enzymes were successfully encapsulated inside the stomatocytes, the AF4 technique was applied. Aliquots of free HRP, empty stomatocytes and HRP-encapsulated stomatocytes were injected in the AFFF separation channel. Enzymes were first eluted while the stomatocytes or HRP loaded stomatocytes were eluted much later owing to their smaller diffusion coefficient. A general method for the AF4 elution of the stomatocytes is shown in Table   S2 . The same analysis method was used to characterize the encapsulation of PtNPs inside the stomatocytes. 
Determination of HRP activities
The activity of HRP-loaded stomatocytes was determined by means of activity assays for HRP using DMB as a substrate. The formation of the oxidized products was monitored by UV−vis spectroscopy. The activity assay was performed at room temperature in 1 cm silica glass cuvettes by mixing 0.8 mL MES buffer solution (5 mM, pH 6.5) of the HRP-encapsulated stomatocytes (0.1 mg mL -1 ) and DMB. The enzymatic reaction was started by the addition of 10 µL H2O2 solution. The final concentrations for HRP, DMB and H2O2 were 5 U mL -1 , 400 µM and 100 mM, respectively. Absorbance at 492 nm was recorded every 60 s. As a control experiment, a free HRP activity assay with DMB as substrate was carried out at the same experimental conditions ( Figure S10 ). The relative activity of the nanoreactors was calculated by comparing the different slopes of the absorption increase in the original linear phase condition. 
Movement analysis
To study in detail the transient behavior of the nanoparticles nanoparticle-tracking analysis (NTA) was used to follow, in real time, the motion of the stomatocytes and calculate their average mean square displacement (MSD). Such a technique was previously implemented to analyze the speed of stomatocytes nanomotors. [4] The NTA technique allows bi-dimensional extraction of coordinates (x, y) by measuring the trajectories of single particles. Per each experiment, 20 stomatocyte nanoparticles were tracked for 30 s. In order to analyze the motion of our platinumencapsulated stomatocytes it was recorded at different concentrations of H2O2. According to Golestanian's self-diffusiophoretic model, [5] we could calculate the average velocity or speed of which is relatively rapid. Such a rapid r would cause such stomatocytes to undergo a random walk for long ∆t and translational velocity can be observed for short ∆t. According to the selfdiffusiophoretic model, the equation ∆r 2 = (4D)∆t +(v 2 )(∆t 2 ) was used to extract the MSD of moving particles and when ∆t is smaller than r, the MSD would display a non-linear fitting. In presence of high H2O2 concentrations (50 mM and 100 mM), moving stomatocytes exhibited indeed a nonlinear fitting, at relatively large ∆t (0.51 s). By correlating fuel concentration to the MSD curve fitting (and its slope) it was observed the lower the fuel concentration the slower the nanomotors move, leading to a transition from an MSD parabolic fit to a linear fit, suggesting a change of the propulsion mechanism from propulsive to diffusive. At high fuel concentrations, bubble propulsion is expected to contribute to motion, which is expect to diminish any effect of rapid r. Therefore, we used the MSD curves (and velocities which were extracted from the fitting of the average MSDs) as a qualitative indication on how active our motors are as a result of their transient binding or unbinding to ATP.
The movement of the nanoparticles was recorded using NTA. The trajectories of the particles were analyzed using NTA software, which registers the corresponding X and Y coordinates. The NTA software tracks the displacement of each particle on a frame-by-frame basis. The recorded trajectories allow for accurate determination of the Brownian particle displacement or mean square displacement (MSD) of every particle, using equations (1) - (3):
where r = radius and t = sampling time
where D is the diffusion coefficient and d = dimensionality (in our case for the NTA A typical reaction mixture for movement analysis was based on 10 μL of a mixture of stomatocytes filled with platinum nanoparticles. The obtained solution (10 mg mL -1 polymer concentration) was diluted at least 500 times with MES buffer (5 mM), attaining a concentration of particles between 10 7 mL -1 and 10 9 mL -1 , measured by NTA. Subsequently, 100 mM fuel was added and the stomatocyte nanomotors were injected into the Nanosight chamber for measurement of their movement.
In a typical procedure, PtNP encapsulated stomatocytes were diluted to the appropriate concentration of 1-9 × 10 8 -10 9 particles per milliliter, then 10 μL H2O2 (35% vol/vol) was added to 1 mL PtNP encapsulated PLL-stomatocytes. The mixture was immediately injected into the sample cell of the Nanosight. A typical video of 30 seconds was recorded. By averaging over was plotted versus the time intervals. (Please note that particles that show drift (due to gas production for example) have been excluded from the MSD calculation. This is an automated process, in which the NTA software cannot track such particles for sufficient time periods and therefore, it clearly indicates that such trajectories are FALSE, and therefore cannot be used.)
Only TRUE trajectories have been used for the MSD analysis.
Figure S14. MSD of Pt loaded stomatocytes in the absence of H2O2. Please note: these stomatocyte particles exhibited typical Brownian motion and therefore, the equation (4D)∆t was used for fitting. Figure S15 . MSD of empty stomatocytes in the presence of 50 mM H2O2. Please note: these stomatocyte particles exhibited typical Brownian motion and therefore, the equation (4D)∆t was used for fitting.
ATP-mediated movement analysis
To 10 mL PtNP encapsulated PLL-stomatocytes with a concentration of 1-9 × 10 8 -10 9 particles per milliliter was added 10 μL ATP to close the opening of the stomatocytes. Then 100 μL H2O2 In a control experiment, AMP (125 μM) was applied instead of ATP (62.5 µM). It was found that the MSD and velocity of the motors did not show any difference in the presence or absence of AMP ( Figure S20 ). 
)
To demonstrate the adaptive motion of the system, 10 μL apyrase was first introduced in a 10 mL motor solution, then 100 μL H2O2 (35% vol/vol) was added. The sample was immediately taken out to do an NTA measurement, after which ATP(r=1) was added. The MSD and velocity of the system before and after addition of ATP were determined, respectively. When the velocity of the nanomotors remained constant, fresh ATP was added again to activate the second cycle.
The effect of apyrase concentration (0.1 U mL -1 and 0.15 U mL -1 ) on the adaptive behavior was investigated in the presence of ATP at a constant concentration (62.5 µM). To study the durability of the motors, the movement analysis was conducted over a period of 40 min, the velocity of the particles was calculated according to MSDs fitting. The speed of the motor remained constant, showing that sufficient H2O2 supported the sustained production of O2 ( Figure S23 ). 
